SecBot SecBot
8-K ·Filed May 29, 2026

WGRX

Wellgistics Health, Inc.
BEARISH
Impact 8/10
Horizonweeks Processed4mo ago SEC0001493152-26-026452
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▼ Bearish

Massive dilutive financing at a $9M market cap company with prior executive departure signals severe financial distress. Monitor for stockholder approval vote (required within ~20 days) and potential Nasdaq delisting if reverse split fails. The mandatory exercise trigger on warrants at $7.50/share (125% of current price) creates a ceiling — any rally toward that level will be met with warrant exercise and further dilution. Avoid long positions until capital structure stabilizes.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+20d
WGRX ▼ -19.48% at T+20d
SHORT call ✓ call won +19.48% · α vs SPY +18.18% · entry $3.85 → $3.10
Next anchor: T+60d due 2mo ago
Entry = T+0 close
May 29, 2026
via day close
T+1d
+10.39%
call -10.39% · α -10.24%
$4.25
settled 5mo ago
T+5d
+12.99%
call -12.99% · α -15.74%
$4.35
settled 5mo ago
T+20d
-19.48%
call +19.48% · α +18.18%
$3.10
settled 4mo ago
T+60d
Pending
due 2mo ago

Price Chart

Loading chart...

Executive Summary

Wellgistics Health raised $21.1M in a PIPE convertible note offering (net proceeds ~$16.9M after original issue discount) with attached warrants, while simultaneously executing a material agreement to acquire drone/biometric IP and form DelivMeds AI. The massive dilution from the convertible notes and warrants, combined with the company's $9M market cap and prior executive departure, creates a highly dilutive capital structure that overwhelms any strategic upside from the acquisition.

Key Financial Metrics

Offering Size
$21.1M

Key Facts

  • Company raised $21,132,812.50 aggregate principal amount of convertible notes (net proceeds $16,906,250 after original issue discount)
  • Investors receive PIPE warrants to purchase 150% of initial principal amount at $7.50/share (125% of closing price), with mandatory exercise trigger at 150% of exercise price
  • Placement agent Dawson James receives 3% cash fee ($507k) and 5-year warrants for 12% of shares issuable upon conversion at $6.25/share
  • Existing public shareholders diluted to ~10.4% post-conversion of Acquisition Preferred per prior cross-filing
  • Company must seek stockholder approval for issuance above 19.99% Exchange Cap (Nasdaq Rule 5635(d))
  • Convertible notes include 9.99% beneficial ownership limitation per holder
  • Company filed reverse stock split (1-for-50) to regain Nasdaq compliance per prior cross-filing
  • Market cap is only ~$9M, making the $21.1M note offering ~234% of market cap
  • Prior CEO departure (8-K filed 8 days ago) signals forced management transition

Financial Impact

Convertible note offering of $21.1M principal ($16.9M net) represents ~234% of current $9M market cap. Potential dilution from conversion and warrants could exceed 10x current shares outstanding.

dilutiondebtshare countmarket cap

Risk Factors

  • Extreme dilution: convertible notes and warrants could increase share count by 10x+
  • Nasdaq delisting risk if reverse stock split fails to regain compliance
  • Stockholder approval required for issuance above 19.99% Exchange Cap — failure would limit conversion
  • Mandatory exercise trigger on warrants creates overhang at $7.50/share
  • Prior CEO departure suggests internal turmoil and forced management transition
  • Company has $4B asset value claim from acquisition but no financing certainty

Market Snapshot

Exchange
Nasdaq
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-026452
Exhibit: ex10-2.htm0001493152-26-026452
Exhibit: ex10-3.htm0001493152-26-026452
Exhibit: ex4-2.htm0001493152-26-026452
12 reports for WGRX
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +52.70%Apr 7, 2026
Filters
Rows
Reports for WGRX — sortable, filterable
TypeNow
Oct 9, 2026
16d ago
S-1/A
BEARISH ★ 7/10
—awaiting T+20——
May 29, 2026
21w ago
8-K
BEARISH ★ 8/10
$3.85 $3.10▲ +19.48%▲ +18.18%—
May 21, 2026
22w ago
8-K
MIXED ★ 7/10
$5.35 $3.18▼ −40.52%▼ −40.85%—
May 19, 2026
22w ago
8-K
MIXED ★ 6/10
$6.45 $3.39▼ −47.44%▼ −48.18%—
May 19, 2026
22w ago
8-K
NEUTRAL ★ 2/10
$8.40 $3.70▼ −55.95%▼ −56.94%—
May 18, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$8.70 $3.69▼ −57.59%▼ −59.17%—
May 8, 2026
24w ago
EFFECT
BEARISH ★ 6/10
$4.21 $4.35▼ −3.33%▼ −3.30%—
Apr 24, 2026
26w ago
10-K/A
BEARISH ★ 7/10
$6.23 $3.82▲ +38.68%▲ +43.64%—
Apr 17, 2026
27w ago
8-K
NEUTRAL ★ 5/10
$6.60 $8.70▲ +31.82%▲ +27.62%—
Apr 15, 2026
27w ago
S-3
NEUTRAL ★ 3/10
$7.37 $4.70▼ −36.18%▼ −42.82%—
Showing 10 of 12

US Market Status

Market Closed — Opens Tue (16h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 29, 2026